Detection of Recurrent Transitional Cell Carcinoma of the Bladder with Nuclear Matrix Protein-22 in a Follow-up Setting

References

• Coebergh J.W. Janssen M. Louwman M. Voogd A. 2001 Cancer Incidence, Car and Survival, 1995–1999: A Report of the Eindhoven Cancer Registry with Cross Border Implications Comprehensive Cancer Centre South (IKZ) Eindhoven
   Google Scholar
• Lokeshwar V.B. Soloway M.S. 2001 Current bladder tumor tests: does their projected utility fulfill clinical necessity? J. Urol. 165 4 1067 1077
   Google Scholar
• Zippe C. Pandrangi L. Potts J.M. Kursh E. Novick A. Agarwal A. 1999 NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer Anticancer Res. 19 4A 2621 2623
   Google Scholar
• Abel P.D. 1997 Follow-up of patients with superficial transitional-cell carcinoma of the bladder Pagano F. Fair W.R. Superficial Bladder Cancer Oxford University Press Oxford 203 216
   Google Scholar
• Sharma S. Zippe C.D. Pandrangi L. Nelson D. Agarwal A. 1999 Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat J. Urol. 162 1 53 57
   Google Scholar
• Sanchez-Carbayo M. Urrutia M. Gonzalez de Buitrago J.M. Navajo J.A. 2001 Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma Cancer 92 11 2820 2828
   Google Scholar
• Ponsky L.E. Sharma S. Pandrangi L. Kedia S. Nelson D. Agarwal A. Zippe C.D. 2001 Screening and monitoring for bladder cancer: refining the use of NMP22 J. Urol. 166 1 75 78
   Google Scholar
• American Joint Committee on Cancer (AJCC) Beahrs O.H. Henson D.E. Hutter R.V.P. Kennedy B.J. 1992 Manual for Staging of Cancer 4th Ed., J.B. Lippincott Philadelphia
   Google Scholar
• Schapers R.F. Pauwels R.P. Wijnen J.T. Arends J.W. Thunnissen F.B. Coebergh J.W. Smeets A.W. Bosman F.T. 1994 A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters Br. J. Urol. 73 6 625 631
   Google Scholar
• Chen Y.T. Hayden C.L. Marchand K.J. Makuch R.W. 1997 Comparison of urine collection methods for evaluating urinary nuclear matrix protein, NMP22, as a tumor marker J. Urol. 158 5 1899 1901
   Google Scholar
• Sackett D.L. Straus S.E. Richardson W.S. Rosenberg W.S. Haynes R.B. 2000 Evidence-Based Medicine. How to Practice and Teach EBM 2nd Ed., Churchill Livingstone Edinburgh
   Google Scholar
• Giannopoulos A. Manousakas T. Mitropoulos D. Botsoli-Stergious E. Constantinides C. Giannopoulou M. Choremi-Papadopoulou H. 2000 Comparative evaluation of the BTA stat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors Urology 55 6 871 875
   Google Scholar
• Carpinito G.A. Stadler W.M. Briggman J.V. Chodak G.W. Church P.A. Lamm D.L. Lange P. Messing E. Pasciak R.M. Reservitz G.B. Ross R.N. Rukstalis D.B. Sarosdy M.F. Soloway M.S. Thiel R.P. Vogelzang N. Hayden C.L 1996 Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract J. Urol. 156 4 1280 1285
   Google Scholar
• Stampfer D.S. Carpinito G.A. Rodriguez-Villanueva J. Willsey L.W. Dinney C.P. Grossman H.B. Fritsche H.A. McDougal W.S 1998 Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder J. Urol. 159 2 394 398
   Google Scholar
• Sanchez-Carbayo M. Herrero E. Megias J. Mira A. Soria F. 1999 Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder BJU Int. 84 6 706 713
   Google Scholar
• Menendez V. Filella X. Alcover J.A. Molina R. Mallafre J.M. Ballesta A.M. Talbot-Wright R. 2000 Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder Anticancer Res. 20 2B 1169 1172
   Google Scholar
• Poulakis V. Witzsch U. De Vries R. Altmansberger H.M. Manyak M.J. Becht E. 2001 A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results BJU Int. 88 7 692 701
   Google Scholar
• Fitzpatrick J.M. West A.B. Butler M.R. Lane V. O'Flynn J.D. 1986 Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection J. Urol. 135 5 920 922
   Google Scholar
• Oosterlinck W. Kurth K.H. Schroder F. Bultinck J. Hammond B. Sylvester R. 1993 A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J. Urol. 149 4 749 752
   Google Scholar
• Oosterhuis J.W.A. Schapers R.F. Pauwels R.P. Janssen M. Newling D.W.W. ten Kate F. 2002 Histologic grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional systems J. Clin. Pathol. In press
   Google Scholar
• Serretta V. Lo P.D. Vasile P. Gange E. Esposito E. Menozzi I. 1998 Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients Urology 52 5 793 796
   Google Scholar
• Kurth K.H. Bouffioux C. Sylvester R. van der Meijden A.P. Oosterlinck W. Brausi M. 2000 Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group Eur. Urol. 37 Suppl. 3 1 9
   Google Scholar
• Hall R.R. Parmar M.K. Richards A.B. Smith P.H. 1994 Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy BMJ 308 6923 257 260
   Google Scholar
• Walsh I.K. Keane P.F. Ishak L.M. Flessland K.A. 2001 The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma Urology 58 4 532 535
   Google Scholar